HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary and secondary arterial fistulas during chronic Q fever.

AbstractOBJECTIVE:
After primary infection with Coxiella burnetii, patients may develop acute Q fever, which is a relatively mild disease. A small proportion of patients (1%-5%) develop chronic Q fever, which is accompanied by high mortality and can be manifested as infected arterial or aortic aneurysms or infected vascular prostheses. The disease can be complicated by arterial fistulas, which are often fatal if they are left untreated. We aimed to assess the cumulative incidence of arterial fistulas and mortality in patients with proven chronic Q fever.
METHODS:
In a retrospective, observational study, the cumulative incidence of arterial fistulas (aortoenteric, aortobronchial, aortovenous, or arteriocutaneous) in patients with proven chronic Q fever (according to the Dutch Chronic Q Fever Consensus Group criteria) was assessed. Proven chronic Q fever with a vascular focus of infection was defined as a confirmed mycotic aneurysm or infected prosthesis on imaging studies or positive result of serum polymerase chain reaction for C. burnetii in the presence of an arterial aneurysm or vascular prosthesis.
RESULTS:
Of 253 patients with proven chronic Q fever, 169 patients (67%) were diagnosed with a vascular focus of infection (42 of whom had a combined vascular focus and endocarditis). In total, 26 arterial fistulas were diagnosed in 25 patients (15% of patients with a vascular focus): aortoenteric (15), aortobronchial (2), aortocaval (4), and arteriocutaneous (5) fistulas (1 patient presented with both an aortocaval and an arteriocutaneous fistula). Chronic Q fever-related mortality was 60% for patients with and 21% for patients without arterial fistula (P < .0001). Primary fistulas accounted for 42% and secondary fistulas for 58%. Of patients who underwent surgical intervention for chronic Q fever-related fistula (n = 17), nine died of chronic Q fever-related causes (53%). Of patients who did not undergo any surgical intervention (n = 8), six died of chronic Q fever-related causes (75%).
CONCLUSIONS:
The proportion of patients with proven chronic Q fever developing primary or secondary arterial fistulas is high; 15% of patients with a vascular focus of infection develop an arterial fistula. This observation suggests that C. burnetii, the causative agent of Q fever, plays a role in the development of fistulas in these patients. Chronic Q fever-related mortality in patients with arterial fistula is very high, in both patients who undergo surgical intervention and patients who do not.
AuthorsSteffi Karhof, Sonja E van Roeden, Jan J Oosterheert, Chantal P Bleeker-Rovers, Nicole H M Renders, Gert J de Borst, Linda M Kampschreur, Andy I M Hoepelman, Olivier H J Koning, Peter C Wever
JournalJournal of vascular surgery (J Vasc Surg) Vol. 68 Issue 6 Pg. 1906-1913.e1 (12 2018) ISSN: 1097-6809 [Electronic] United States
PMID29685511 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Aneurysm, Infected (diagnosis, microbiology, mortality, surgery)
  • Arteriovenous Fistula (diagnosis, microbiology, mortality, surgery)
  • Bronchial Fistula (diagnosis, microbiology, mortality, surgery)
  • Cutaneous Fistula (diagnosis, microbiology, mortality, surgery)
  • Endocarditis, Bacterial (diagnosis, microbiology, mortality, surgery)
  • Female
  • Humans
  • Incidence
  • Intestinal Fistula (diagnosis, microbiology, mortality, surgery)
  • Male
  • Middle Aged
  • Netherlands (epidemiology)
  • Prognosis
  • Prosthesis-Related Infections (diagnosis, microbiology, mortality, surgery)
  • Q Fever (diagnosis, microbiology, mortality, surgery)
  • Registries
  • Retrospective Studies
  • Risk Factors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: